Intracerebral adrenal medulla grafts: a review.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Experimental Neurology

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-4886(90)90026-OPMID 1977606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nerve fiber production by intraocular adrenal medullary grafts: Stimulation by nerve growth factor or sympathetic denervation of the host iris

  2004cited by this paper
• Survival of dissociated adrenal chromaffin cells of rat and monkey transplanted into rat brain

  2004cited by this paper
• Long-term effects of dexamethasone and nerve growth factor on adrenal medullary cells cultured from young adult rats

  2004cited by this paper
• Comparison of adrenal and foetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions

  2004cited by this paper
• Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain

  2004cited by this paper
• Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues

  2004cited by this paper
• Fluorescence histochemical evidence for axonal growth and secretion from transplanted adrenal medullary tissue

  2004cited by this paper
• Brain tissue transplantation in neonatal rats prevents a lesion-induced syndrome of adipsia, aphagia and akinesia

  2004cited by this paper
• Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior

  2004cited by this paper
• Ultrastructural evidence for the development of adrenal medullary grafts in the brain

  2004cited by this paper
• Fate of intraocular chromaffin cell suspensions: role of initial nerve growth factor support

  2004cited by this paper
• Fine structure of adrenal medullary grafts in the pain modulatory regions of the rat periaqueductal gray

  2004cited by this paper
• Cell adhesion molecules in adrenal medulla grafts: enhancement of chromaffin cell L1/Ng-CAM expression and reorganization of extracellular matrix following transplantation.

  1990cited by this paper
• The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies.

  1990cited by this paper
• Host-graft relationships of isolated bovine chromaffin cells in rat periaqueductal grey

  1990cited by this paper
• Cell adhesion molecules (CAMs) in adrenal medulla in situ and in vitro: enhancement of chromaffin cell L1/Ng-CAM expression by NGF.

  1990cited by this paper
• Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice.

  1990cited by this paper
• Effects of adrenal medulla grafts in neonatal rat hosts on subsequent bilateral substantia nigra lesions

  1990cited by this paper
• Importance of catecholamine release for the functional action of intrastriatal implants of adrenal medullary cells: pharmacological analysis and in vivo electrochemistry.

  1990cited by this paper
• Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model

  1990cited by this paper
• Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease

  1990cited by this paper
• Mechanisms of action of adrenal medulla grafts: the possible role of peripheral and central dopamine systems.

  1990cited by this paper
• Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

  1990cited by this paper
• Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year.

  1990cited by this paper
• Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

  1990cited by this paper
• Graft of adrenal tissue into the nervous system.

  1990cited by this paper
• Families of neural cell adhesion molecules

  1990cited by this paper
• Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled release of dopamine from a silicone polymer pellet placed into the denervated striatum.

  1990cited by this paper
• Preliminary report on adrenal medullary grafting from the American Association of Neurological Surgeons Graft Project.

  1990cited by this paper
• Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

  1990cited by this paper
• Adrenal medulla graft induced recovery of function in an animal model of Parkinson's disease: possible mechanisms of action.

  1990cited by this paper
• Chapter 72 Is autologous transplant of adrenal medulla into the striatum an effective therapy for Parkinson's disease?

  1990cited by this paper
• Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants.

  1990cited by this paper
• Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients.

  1989cited by this paper
• Adrenal grafting for Parkinson's disease: a role for substance P.

  1989cited by this paper
• Autologous adrenal medullary transplant in progressive supranuclear palsy

  1989cited by this paper
• Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.

  1989cited by this paper
• Postmortem analysis of adrenal–medulla–to–caudate autograft in a patient with parkinson's disease

  1989cited by this paper
• Autopsy findings in a patient who had an adrenal‐to‐brain transplant for Parkinson's disease

  1989cited by this paper
• Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease.

  1989cited by this paper
• Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease

  1989cited by this paper
• Survival and neuritic growth of sympathoadrenal (chromaffin) precursor cells in vitro

  1989cited by this paper
• Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.

  1989cited by this paper
• Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants.

  1989cited by this paper
• Effect of striatal implantation of bovine adrenal chromaffin cells on turning behavior in a rat model of Parkinson's disease.

  1989cited by this paper
• ADRENAL MEDULLARY TRANSPLANT TO THE BRAIN FOR PARKINSONʼS DISEASE. NEUROPATHO-LOGY OF AN UNSUCCESSFUL CASE: 116

  1989cited by this paper
• Basic Fibroblast Growth Factor in the Adrenal Gland

  1989cited by this paper
• Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients.

  1989cited by this paper
• Aged adrenal medullary tissue survives intraocular grafting, forms nerve fibers and responds to nerve growth factor

  1989cited by this paper
• Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.

  1989cited by this paper
• Adrenal medullary autografts in patients with Parkinson's disease.

  1989cited by this paper
• An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats.

  1989cited by this paper
• Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease.

  1988cited by this paper
• Pharmacologic consequences of the vascular permeability of chromaffin cell transplants in CNS pain modulatory regions.

  1988cited by this paper
• Paraneuronal grafts in unilateral 6-hydroxydopamine-lesioned rats: morphological aspects of adrenal chromaffin and carotid body glomus cell implants.

  1988cited by this paper
• An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.

  1988cited by this paper
• Comparison of adrenal medullary, carotid body and PC12 cell grafts in 6-OHDA lesioned rats.

  1988cited by this paper
• Survival of adenohypophyseal homologous transplants in the rat striatum associated with prolactin-like immunoreactivity in the surrounding neuropil of the striatum.

  1988cited by this paper
• The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients.

  1988cited by this paper
• Study of adrenal medullary tissue transplantation to striatum in parkinsonism.

  1988cited by this paper
• Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions.

  1988cited by this paper
• Transplantation of adrenal medulla into spinal cord for pain relief: disappointing outcome.

  1988cited by this paper
• Interleukin-1 is an astroglial growth factor in the developing brain

  1988cited by this paper
• Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF)

  1988cited by this paper
• A potent dopamine-releasing factor is present in high concentrations in the rat adrenal gland.

  1988cited by this paper
• An improved procedure for pressure-free insertion of tissue into the central nervous system.

  1988cited by this paper
• Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

  1988cited by this paper
• Adrenal medullary cells transmute into dopaminergic neurons in dopamine-depleted rat caudate and ameliorate motor disturbances.

  1988cited by this paper
• Fine structural correlates of vascular permeability of chromaffin cell transplants in CNS pain modulatory regions.

  1988cited by this paper
• Adrenal medullary autografts into the basal ganglia of Cebus monkeys: graft viability and fine structure.

  1988cited by this paper
• Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration.

  1988cited by this paper
• Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease.

  1988cited by this paper
• A comparison of intraventricular and intraparenchymal cerebellar allografts in rat brain: evidence for normal phosphorylation of neurofilaments.

  1988cited by this paper
• Detection of HTLV‐III‐specific IgG bands in the CSF from a patient with AIDS and encephalitis

  1988cited by this paper
• Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys.

  1988cited by this paper
• Neurochemical correlates of behavioral changes following intraventricular adrenal medulla grafts: intraventricular microdialysis in freely moving rats.

  1988cited by this paper
• Eosinophil‐induced neurotoxicity

  1988cited by this paper
• Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients.

  1988cited by this paper
• Cortical lesions increase reinnervation of the dorsal striatum by substantia nigra grafts.

  1988cited by this paper
• Organization, fine structure, and viability of the human adrenal medulla: Considerations for neural transplantation

  1988cited by this paper
• Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats.

  1988cited by this paper
• Neuropsychological effects of brain autograft of adrenal medullary tissue for the treatment of Parkinson's disease

  1988cited by this paper
• Human organ donor adrenals: fine structure, plasticity and viability.

  1988cited by this paper
• Chapter 73 Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients

  1988cited by this paper
• Chapter 81 An improved procedure for pressure-free insertion of tissue into the central nervous system

  1988cited by this paper
• Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve

  1987cited by this paper
• Rat astrocytes and Schwann cells in culture synthesize nerve growth factor-like neurite-promoting factors.

  1987cited by this paper
• Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

  1987cited by this paper
• Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

  1987cited by this paper
• The nerve growth factor: thirty‐five years later.

  1987cited by this paper
• Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen

  1987cited by this paper
• Older dopaminergic neurons do not recover from the effects of MPTP.

  1987cited by this paper
• Transplantation of cultured human adrenal chromaffin cells into 6‐hydroxydopamine‐lesioned rat brain

  1987cited by this paper
• Adrenal medulla grafts produce blood-brain barrier dysfunction.

  1987cited by this paper
• Alterations in nociception following adrenal medullary transplants into the rat periaqueductal gray

  1987cited by this paper
• Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra.

  1987cited by this paper
• Neocortical transplants in the mammalian brain lack a blood-brain barrier to macromolecules.

  1987cited by this paper
• Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.

  1986cited by this paper
• Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord.

  1986cited by this paper
• Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro.

  1986cited by this paper

• Dopamine Cell-Based Replacement Therapies.

  2024cites this paper
• Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

  2024cites this paper
• Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells

  2022cites this paper
• Development of 3D Cerebral Aggregates in the Brain Ventricles of Adult Mice

  2021cites this paper
• Cell transplantation therapy for Parkinson's disease

  2020cites this paper
• Mechanisms and use of neural transplants for brain repair.

  2017cites this paper
• La Enfermedad de Parkinson: Etiología, Tratamientos y Factores Preventivos

  2017cites this paper
• Cell-based therapies for Parkinson disease—past insights and future potential

  2015cites this paper
• Omental transplantation for neurodegenerative diseases.

  2014cites this paper
• Review Article Omental transplantation for neurodegenerative diseases

  2014cites this paper
• Editorial : Reconstruction of Brains and Journals

  2014cites this paper
• Organotypic cultures as tools for optimizing central nervous system cell therapies.

  2013cites this paper
• Développement de microcarriers pharmacologiquement actifs transportant des cellules souches pour le traitement de maladies neurodégénératives

  2013cites this paper
• Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons.

  2012cites this paper
• Chromaffin cell transplants: from the lab to the clinic.

  2012cites this paper
• Behavioural analysis of 6-hydroxydopamine rodent models of Parkinson's disease

  2012cites this paper
• Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons

  2012cites this paper
• The Role of Cell Therapy in the Treatment of Epilepsy: Lessons from Animal Models and Clinical Trials

  2011cites this paper
• Cell Therapy for Parkinson’s Disease: Status and Perspectives

  2011cites this paper
• Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies

  2011cites this paper
• Strategies for the Development of Cell Lines for Ex Vivo Gene Therapy in the Central Nervous System

  2011cites this paper
• In vitro differentiation of the immortalized mesencephalic progenitor cell line CSM14.1 occurs independently from haematopoietic cytokines.

  2010cites this paper
• The Future of Cell Transplantation

  2009cites this paper
• Terapia celular y terapia génica ex vivo: avances en el tratamiento de enfermedades del sistema nervioso central

  2009cites this paper
• Cell replacement therapy for Parkinson's disease.

  2009cites this paper
• [Cell and ex vivo gene therapy: advances in the treatment of central nervous system disorders].

  2009cites this paper
• Investigating the Dopaminergic Synapse In Vivo. II. Molecular Imaging Studies in Small Laboratory Animals

  2007cites this paper
• 28 – Human Embryonic Stem Cells, Dopaminergic Neurons, and Pathways for Developing a Parkinson's Disease Therapy

  2007cites this paper
• Progress and Challenges in Immunoisolation for CNS Cell Therapy

  2006cites this paper
• Transplantation in Parkinson's disease: The future looks bright.

  2006cites this paper
• Manipulation of precursor cells for the replacement of complex circuitry lost in neurodegenerative disease

  2005cites this paper
• A selective tachykinin receptor agonist promotes differentiation but not survival of rat chromaffin cells in vitro

  2004cites this paper
• Neuroprotective Effects of Encapsulated CNTF-Producing Cells in a Rodent Model of Huntington's Disease are Dependent on the Proximity of the Implant to the Lesioned Striatum1

  2004cites this paper
• Ultrastructural analysis of graft-to-host connections, with special reference to dopamine-neuropeptide Y interactions in the rat striatum, after transplantation of fetal mesencephalon cells

  2004cites this paper
• The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders.

  2004cites this paper
• Transplantation of Mouse Embryonic Stem Cell-Derived Dopaminergic Neurons in a Unilateral 6-Hydroxydopamine Lesion Rat Model of Parkinson’s Disease

  2004cites this paper
• The cellular repair of the brain in Parkinson's disease--past, present and future.

  2004cites this paper
• Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo.

  2004cites this paper
• Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat

  2004influential citation
• Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.

  2004cites this paper
• Co‐transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6‐hydroxydopamine‐lesioned rats: implications for Parkinson's disease

  2004cites this paper
• Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test

  2004cites this paper
• Studies of a Human Neuron-Like Cell Line in Stroke and Spinal Cord Injury

  2003cites this paper
• Functional and Morphological Characteristics of Bovine Adrenal Chromaffin Cells on Macroporous Poly(D,L-lactide-co-glycolide) Scaffolds

  2003cites this paper
• Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes

  2002cites this paper
• Enhanced viability and neuronal differentiation of neural progenitors by chromaffin cell co-culture.

  2002cites this paper
• Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP‐treated monkeys: Feasibility relevant to multiple‐target grafting as a therapy for Parkinson's disease

  2002cites this paper
• Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseases.

  2001cites this paper
• Microencapsulated bovine chromaffin cell xenografts into hemiparkinsonian rats: a drug-induced rotational behavior and histological changes analysis.

  2001cites this paper
• Immunoisolation cell therapy for CNS diseases.

  2001cites this paper
• Automated Method for Isolation of Adrenal Medullary Chromaffin Cells from Neonatal Porcine Glands

  2001cites this paper
• Update on Immunoisolation Cell Therapy for CNS Diseases

  2001cites this paper
• Cell Transplantation for the Treatment of Parkinson's Disease

  2001cites this paper
• Xenotransplantation of microencapsulated bovine chromaffin cells into hemiparkinsonian monkeys

  2000cites this paper
• Restorative surgery of the central nervous system by means of tissue engineering using NeuroGel implants

  2000cites this paper
• Delivery of therapeutic molecules into the CNS.

  2000cites this paper
• Cell delivery to the central nervous system.

  2000cites this paper
• Transplantation of Encapsulated Cells into the Central Nervous System

  1999cites this paper
• An overview of central nervous system transplantation in human disease.

  1999cites this paper
• Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease.

  1999cites this paper
• Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Clínica Puerta de Hierro Neural Transplantation Group.

  1999cites this paper
• Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient. A preliminary report.

  1999cites this paper
• Release properties and functional integration of noradrenergic‐rich tissue grafted to the denervated spinal cord of the adult rat

  1999cites this paper
• UCL 1684: a potent blocker of Ca2+ -activated K+ channels in rat adrenal chromaffin cells in culture.

  1999cites this paper
• Treatment of diseases of the central nervous system using encapsulated cells.

  1999cites this paper
• Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells.

  1998cites this paper
• Adrenal medullary transplants attenuate sensorimotor dysfunction in rats with peripheral neuropathy.

  1998cites this paper
• Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury.

  1998cites this paper
• Cardiomyocyte transplantation in a porcine myocardial infarction model.

  1998cites this paper
• Cardiomyocyte Transplantation in a Porcine Myocardial Infarction Model

  1998cites this paper
• Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats.

  1998cites this paper
• Poly(vinyl alcohol) synthetic polymer foams as scaffolds for cell encapsulation.

  1998cites this paper
• Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease.

  1998cites this paper
• Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review.

  1998cites this paper
• The Use of Neurotoxins to Lesion Catecholamine-Containing Neurons to Model Clinical Disorders

  1998cites this paper
• Gene therapy approaches to Parkinson's disease: preclinical to clinical trials, or what steps to take to get there from here?

  1997cites this paper
• Transplantation of Dopamine-Synthesizing Cells in Parkinson’s Disease: Experimental Data and Clinical Application

  1997cites this paper
• Radiosurgical lesioning of the caudate nucleus as a treatment for parkinsonism: a preliminary report.

  1997cites this paper
• Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers.

  1997cites this paper
• Neural Transplantation in Parkinson's Disease

  1997cites this paper
• Human Fetal Astrocytes as an Ex Vivo Gene Therapy Vehicle for Delivering Biologically Active Nerve Growth Factor

  1997cites this paper
• The multifunctionality of FGF-2 in the adrenal medulla

  1997cites this paper
• Neural transplantation.

  1996cites this paper
• Bovine chromaffin cells for CNS transplantation do not elicit xenogeneic T cell proliferative responses in vitro.

  1996cites this paper
• Growth factors in chromaffin cells.

  1996cites this paper
• Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: basic and clinical studies.

  1996cites this paper
• Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents.

  1996cites this paper
• Dopaminergic responses to striatal damage.

  1996cites this paper
• Applications of gene therapy to the CNS.

  1996cites this paper
• Bovine Chromaffin Cells for CNS Transplantation do not Elicit Xenogeneic T Cell Proliferative Responses in Vitro

  1996cites this paper
• Neuroprotection and Neurotransplantation Strategies in Models of Parkinson’s Disease

  1996cites this paper
• Superior cervical ganglion regenerating axons through peripheral nerve grafts and reversal of behavioral deficits in hemiparkinsonian rats.

  1996cites this paper
• Chromaffin cell transplants in the CNS: Basic and clinical update

  1996cites this paper
• Continued Presence of Intrastriatal but not Intraventricular Polymer-Encapsulated PC12 Cells is Required for Alleviation of Behavioral Deficits in Parkinsonian Rodents

  1996cites this paper
• Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation.

  1995cites this paper
• Will brain tissue grafts become an important therapy to restore visual function in cerebrally blind patients

  1995cites this paper
• CNS transplant utility may surive even their hasty clinical application

  1995cites this paper
• Therapeutic uses for neural grafts: Progress slowed but not abandoned

  1995cites this paper
• Multiple obstacles to gene therapy in the brain

  1995cites this paper
• Adrenal chromaffin cells transdifferentiate in response to basic fibroblast growth factor and show directed outgrowth to a nerve growth factor source in vivo.

  1995cites this paper